Butterfly Network Adds Medical Device Veteran to Board Amid Growth Push
Event summary
- Butterfly Network appoints Caroll H. Neubauer to its Board of Directors, effective May 18, 2026.
- Neubauer brings 30 years of experience at B. Braun, where he helped grow revenue from $1B to $8B.
- He will serve on the Compensation and Technology Committees.
- Neubauer is an Executive Advisor to Water Street Healthcare Partners and a former AdvaMed Board member.
The big picture
Butterfly Network is bolstering its governance with a seasoned medical device executive as it transitions from hardware-focused growth to a multi-faceted platform strategy. Neubauer's track record in scaling B. Braun and his deep industry connections could prove valuable as Butterfly pursues profitability and expands its AI-driven ultrasound ecosystem. His addition follows a period of rapid innovation in semiconductor-based medical imaging, where Butterfly competes with both traditional ultrasound manufacturers and emerging AI healthtech players.
What we're watching
- Strategic Scaling
- How Neubauer's experience in global medical device markets will influence Butterfly's international expansion.
- Regulatory Navigation
- Whether his background in repealing the U.S. medical device tax can aid Butterfly's policy engagements.
- Profitability Timing
- The pace at which Neubauer's commercial partnerships expertise accelerates Butterfly's path to profitability.
Related topics